Trial Details
COMPLETEDBasic Information
| Clinical ID | c1797 |
|---|---|
| Identifier | NCT04462900 |
| Trial Title | Evaluate the Safety of Linaclotide in IBS-C Patients in China |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome-IBS |
| Interventions | - |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Baotou |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2020-09-18 |
|---|---|
| Primary Completion Date | 2023-02-03 |
| Completion Date | 2023-02-03 |